BioLineRx Ltd.
BLRX
$2.55
-$0.04-1.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.03M | -1.60M | -1.39M | -977.00K | -3.94M |
| Total Depreciation and Amortization | 78.00K | 88.00K | -19.00K | 119.00K | 176.00K |
| Total Amortization of Deferred Charges | -- | -- | 82.00K | 0.00 | 0.00 |
| Total Other Non-Cash Items | -554.00K | -1.28M | -1.96M | -1.07M | 1.72M |
| Change in Net Operating Assets | 285.00K | 513.00K | 79.00K | -177.00K | 1.87M |
| Cash from Operations | -3.22M | -2.28M | -3.20M | -2.11M | -177.00K |
| Capital Expenditure | 6.00K | -6.00K | -25.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -11.00K | 11.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.34M | 2.71M | -312.00K | 3.68M | -3.72M |
| Cash from Investing | 6.35M | 2.70M | -337.00K | 3.67M | -3.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.18M | -1.18M | -1.25M | -1.26M | -1.26M |
| Issuance of Common Stock | 44.00K | -- | 0.00 | 340.00K | 2.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.14M | -1.18M | -1.25M | -916.00K | 1.60M |
| Foreign Exchange rate Adjustments | 132.00K | 11.00K | 125.00K | 74.00K | 432.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.12M | -746.00K | -4.66M | 725.00K | -1.85M |